SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,790 | +45578.6% | 254,257 | +1081.3% | 0.03% | – |
| Q2 2023 | $28 | -26.3% | 21,524 | 0.0% | 0.00% | – |
| Q1 2023 | $38 | -44.1% | 21,524 | 0.0% | 0.00% | – |
| Q4 2022 | $68 | -99.9% | 21,524 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $105,000 | +18.0% | 21,524 | 0.0% | 0.00% | – |
| Q2 2022 | $89,000 | -28.8% | 21,524 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $125,000 | -22.4% | 21,524 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $161,000 | -17.0% | 21,524 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $194,000 | -24.8% | 21,524 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $258,000 | -4.4% | 21,524 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $270,000 | -19.6% | 21,524 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $336,000 | +65.5% | 21,524 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $203,000 | +5.2% | 21,524 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $193,000 | +40.9% | 21,524 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $137,000 | -19.4% | 21,524 | +5.9% | 0.00% | 0.0% |
| Q4 2019 | $170,000 | -7.6% | 20,319 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $184,000 | -16.0% | 20,319 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $219,000 | +12.9% | 20,319 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $194,000 | -16.7% | 20,319 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $233,000 | -32.3% | 20,319 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $344,000 | +19.0% | 20,319 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $289,000 | -25.1% | 20,319 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $386,000 | -9.4% | 20,319 | -21.8% | 0.00% | 0.0% |
| Q4 2017 | $426,000 | +9.2% | 25,992 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $390,000 | +70.3% | 25,992 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $229,000 | +69.6% | 25,992 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $135,000 | +70.9% | 25,992 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $79,000 | -34.2% | 25,992 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $120,000 | -20.0% | 25,992 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $150,000 | -4.5% | 25,992 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $157,000 | -33.8% | 25,992 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $237,000 | +61.2% | 25,992 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $147,000 | -49.0% | 25,992 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $288,000 | -30.8% | 25,992 | -2.0% | 0.00% | -33.3% |
| Q1 2015 | $416,000 | +3.2% | 26,515 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $403,000 | +40.9% | 26,515 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $286,000 | -29.4% | 26,515 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $405,000 | -15.4% | 26,515 | 0.0% | 0.00% | -25.0% |
| Q1 2014 | $479,000 | +13.0% | 26,515 | -13.1% | 0.00% | 0.0% |
| Q4 2013 | $424,000 | +32.5% | 30,500 | 0.0% | 0.00% | +33.3% |
| Q3 2013 | $320,000 | +34.5% | 30,500 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $238,000 | – | 30,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |